Exposure-response association seen between trihalomethanes and CKD risk; highest risk seen for brominated trihalomethanes.

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney disease (CKD), highlighting its dual-action benefits.

U.S. and state officials say the consolidation of the public health agency’s vast trove of information could expose patients and will delay analysis of long-term trends.

Learn how early detection, biomarkers, and prevention strategies can improve outcomes in acute kidney injury and reduce CKD risk.

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave off the disease’s worst effects.

Powered by a 40.3-horsepower* Kubota diesel engine, a digging depth of 11 feet, 2.3 inches, and a bucket breakout force of 9,397 pounds, the KX040-5 can tackle the toughest tasks on the jobsite.

Non-Hispanic Black populations face the highest risk of death from chronic kidney disease (CKD)–associated cardiac arrest, a study found.

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes organization, updated recommendations are presented for the evaluation, management, and treatment of ...

Akebia plans to kick off a phase 3 trial to assess Vafseo as a potential treatment for anemia in late-stage CKD patients who aren’t on dialysis.

Review information on how to manage the costs of kidney disease treatments like dialysis, medication, and transplantation, and resources for support.

Updated chronic kidney disease guidelines recommended including cystatin C with creatinine to estimate glomerular filtration rate. Point-of-care-testing for creatinine and urine albumin ...